CNBX Pharmaceuticals annual gross margin
2016
2017
CNBX Pharmaceuticals Gross Margin Growth & History (CNBX)
CNBX Pharmaceuticals's gross margin was 100.00% for fiscal 2017.
View full CNBX Pharmaceuticals company overviewCNBX Pharmaceuticals annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2017 | 2017-08-31 | 100.00% | 0.00 pp |
| 2016 | 2016-08-31 | 100.00% | — |
CNBX Pharmaceuticals quarterly gross margin
Q2.16
Q3.16
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q1.19
Q2.24
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 | 2024-02-29 | 84.69% | −15.31 pp |
| Q1 2019 | 2018-11-30 | 100.00% | 0.00 pp |
| Q2 2018 | 2018-02-28 | 100.00% | 0.00 pp |
| Q1 2018 | 2017-11-30 | 100.00% | 0.00 pp |
| Q4 2017 | 2017-08-31 | 100.00% | 0.00 pp |
| Q3 2017 | 2017-05-31 | 100.00% | — |
| Q2 2017 | 2017-02-28 | 100.00% | — |
| Q3 2016 | 2016-05-31 | 100.00% | — |
| Q2 2016 | 2016-02-29 | 100.00% | — |
CNBX Pharmaceuticals gross margin trends
Across the available reported history, CNBX Pharmaceuticals's gross margin increased from 100.00% to 100.00%, a change of 0.00 percentage points. The latest reported quarter, Q2 2024, shows 84.69%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CNBX Pharmaceuticals filings at SEC.gov ↗